Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abciximab versus placebo for coronary microembolization detection during PCI in stable angina
2010-019688-12Phase 4Completed
- Sponsor
- Friedrich Schiller University Jena
- Start
- Apr 2010
- Modality
- Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics, Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in angina pectoris comparing Abciximab + PCI with Placebo + PCI (2 arms). Primary endpoints: HITS during predilation and HITS during stent deployment. Started Apr 2010; status: completed.
02
Drugs
abciximab
03
Conditions
angina pectoris
Beyond the preview
Go deeper on 2010-019688-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019688-12.